Kv1.1

1

Olamendi-Portugal T et al. Isolation, chemical and functional characterization of several new K(+)-channel blocking peptides from the venom of the scorpion Centruroides tecomanus.
Toxicon, 2016 Jun 1 , 115 (1-12).

2

Voigt N et al. Atrial-Selective Potassium Channel Blockers.
Card Electrophysiol Clin, 2016 Jun , 8 (411-21).

3

Subramani B et al. Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell.
Cytotechnology, 2016 Jan 28 , ().

4

Rash JE et al. KV1 channels identified in rodent myelinated axons, linked to Cx29 in innermost myelin: Support for electrically-active myelin in mammalian saltatory conduction.
J. Neurophysiol., 2016 Jan 13 , (jn.01077.2015).

5

Hivert B et al. Assembly of juxtaparanodes in myelinating DRG culture: Differential clustering of the Kv1/Caspr2 complex and scaffolding protein 4.1B.
Glia, 2016 Feb 3 , ().

6

Kim KX et al. Maturation of NaV and KV Channel Topographies in the Auditory Nerve Spike Initiator before and after Developmental Onset of Hearing Function.
J. Neurosci., 2016 Feb 17 , 36 (2111-8).

7

Ye F et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Toxins (Basel), 2016 , 8 ().

8

Wang X et al. A single-point mutation enhances dual functionality of a scorpion toxin.
Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2015 Sep 7 , 179 (72-78).

9

Yin N et al. Silver nanoparticle exposure induces rat motor dysfunction through decrease in expression of calcium channel protein in cerebellum.
Toxicol. Lett., 2015 Sep 2 , 237 (112-20).

10

Murray JK et al. Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.
J. Med. Chem., 2015 Sep 10 , 58 (6784-802).

11

Nanayakkara S et al. Whole-exome sequencing reveals genetic variants associated with chronic kidney disease characterized by tubulointerstitial damages in North Central Region, Sri Lanka.
Environ Health Prev Med, 2015 Sep , 20 (354-9).

12

Glasscock E et al. Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation.
Basic Res. Cardiol., 2015 Sep , 110 (505).

13

Fellerhoff-Losch B et al. Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway.
J Neural Transm (Vienna), 2015 Nov 26 , ().

14

Kuzmenkov AI et al. Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY.
J. Biol. Chem., 2015 May 8 , 290 (12195-209).

15

Langford DJ et al. Variations in potassium channel genes are associated with distinct trajectories of persistent breast pain after breast cancer surgery.
Pain, 2015 Mar , 156 (371-80).

16

Tsantoulas C Emerging potassium channel targets for the treatment of pain.
Curr Opin Support Palliat Care, 2015 Jun , 9 (147-54).

17

Chang SC et al. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
FEBS J., 2015 Jun , 282 (2247-59).

18

Kohl B et al. Solid phase synthesis, NMR structure determination of α-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity.
Toxicon, 2015 Jul , 101 (70-8).

19

Kim do Y et al. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition.
Ann. Neurol., 2015 Jul , 78 (77-87).

20

Daly D et al. Porphyrin derivatives as potent and selective blockers of neuronal Kv1 channels.
Chem. Commun. (Camb.), 2015 Jan 21 , 51 (1066-9).

21

Wang X et al. Mesomartoxin, a new K(v)1.2-selective scorpion toxin interacting with the channel selectivity filter.
Biochem. Pharmacol., 2015 Jan 15 , 93 (232-9).

22

Chen J et al. Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2015 Jan 1 , 308 (R18-27).

23

Kuwabara S et al. Acquired and genetic channelopathies: in vivo assessment of axonal excitability.
Exp. Neurol., 2015 Jan , 263 (368-71).

24

Sosanya NM et al. Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis.
Neurobiol. Dis., 2015 Jan , 73 (96-105).

25

Pennington MW et al. Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK.
Mar Drugs, 2015 Jan , 13 (529-42).

26

Xiang F et al. Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region.
Toxins (Basel), 2015 Jan , 7 (34-42).

27

Bialowas A et al. Analog modulation of spike-evoked transmission in CA3 circuits is determined by axonal Kv1.1 channels in a time-dependent manner.
Eur. J. Neurosci., 2015 Feb , 41 (293-304).

28

Kole MJ et al. Selective Loss of Presynaptic Potassium Channel Clusters at the Cerebellar Basket Cell Terminal Pinceau in Adam11 Mutants Reveals Their Role in Ephaptic Control of Purkinje Cell Firing.
J. Neurosci., 2015 Aug 12 , 35 (11433-44).

29

Smith KE et al. Phosphoinositide Modulation of Heteromeric Kv1 Channels Adjusts Output of Spiral Ganglion Neurons from Hearing Mice.
J. Neurosci., 2015 Aug 12 , 35 (11221-32).

30

Chen J et al. SjAPI-2 is the first member of a new neurotoxin family with Ascaris-type fold and KCNQ1 inhibitory activity.
Int. J. Biol. Macromol., 2015 Aug , 79 (504-10).

31

Aiba I et al. Spreading depolarization in the brainstem mediates sudden cardiorespiratory arrest in mouse SUDEP models.
Sci Transl Med, 2015 Apr 8 , 7 (282ra46).

32

Wang J et al. Oral administration of putrescine and proline during the suckling period improves epithelial restitution after early weaning in piglets.
J. Anim. Sci., 2015 Apr , 93 (1679-88).

33

Hall MK et al. Complex N-Glycans Influence the Spatial Arrangement of Voltage Gated Potassium Channels in Membranes of Neuronal-Derived Cells.
PLoS ONE, 2015 , 10 (e0137138).

34

Bartok A et al. An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility.
Sci Rep, 2015 , 5 (18397).

35

Serikawa T et al. Advances on genetic rat models of epilepsy.
Exp. Anim., 2015 , 64 (1-7).

36

Streit AK et al. RNA editing in the central cavity as a mechanism to regulate surface expression of the voltage-gated potassium channel Kv1.1.
J. Biol. Chem., 2014 Sep 26 , 289 (26762-71).

37

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

38

Carrisoza-Gaytán R et al. Differential expression of the Kv1 voltage-gated potassium channel family in the rat nephron.
J. Mol. Histol., 2014 Oct , 45 (583-97).

39

Imperial JS et al. A family of excitatory peptide toxins from venomous crassispirine snails: using Constellation Pharmacology to assess bioactivity.
Toxicon, 2014 Oct , 89 (45-54).

40

Ranzato E et al. Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Cell Calcium, 2014 Oct , 56 (285-95).

41

Moore BM et al. The Kv1.1 null mouse, a model of sudden unexpected death in epilepsy (SUDEP).
Epilepsia, 2014 Nov , 55 (1808-16).

42

Simeone TA et al. In vivo ketogenic diet treatment attenuates pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices from epileptic Kv 1.1α knockout mice.
Epilepsia, 2014 May , 55 (e44-9).

43

Lassche S et al. A novel KCNA1 mutation causing episodic ataxia type I.
Muscle Nerve, 2014 Mar 18 , ().

44

Rodríguez-Ravelo R et al. A K⁺ channel blocking peptide from the Cuban scorpion Rhopalurus garridoi.
Peptides, 2014 Mar , 53 (42-7).

45

Kirizs T et al. Distinct axo-somato-dendritic distributions of three potassium channels in CA1 hippocampal pyramidal cells.
Eur. J. Neurosci., 2014 Jun , 39 (1771-83).

46

Luna-Ramírez K et al. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
Mol. Pharmacol., 2014 Jul , 86 (28-41).

47

Teichert RW et al. Using constellation pharmacology to define comprehensively a somatosensory neuronal subclass.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jan 27 , ().

48

Rashid MH et al. Free energy simulations of binding of HsTx1 toxin to Kv1 potassium channels: the basis of Kv1.3/Kv1.1 selectivity.
J Phys Chem B, 2014 Jan 23 , 118 (707-16).

49

Jiang L et al. Molecular cloning, bioinformatics analysis and functional characterization of HWTX-XI toxin superfamily from the spider Ornithoctonus huwena.
Peptides, 2014 Jan 10 , ().

50

Hoang AN et al. Vietnamese Heterometrus laoticus scorpion venom: evidence for analgesic and anti-inflammatory activity and isolation of new polypeptide toxin acting on Kv1.3 potassium channel.
Toxicon, 2014 Jan , 77 (40-8).

51

Song HP et al. Atractylodes macrocephala Koidz promotes intestinal epithelial restitution via the polyamine--voltage-gated K+ channel pathway.
J Ethnopharmacol, 2014 Feb 27 , 152 (163-72).

52

Gu Y et al. Physiological and Pathological Functions of Mechanosensitive Ion Channels.
Mol. Neurobiol., 2014 Feb 15 , ().

53

Wolfram V et al. The transcription factors islet and Lim3 combinatorially regulate ion channel gene expression.
J. Neurosci., 2014 Feb 12 , 34 (2538-43).

54

Sheng J et al. Electrophysiology of human cardiac atrial and ventricular telocytes.
J. Cell. Mol. Med., 2014 Feb , 18 (355-62).

55

Bhuyan R et al. Conformational Dynamics of Shaker-Type Kv1.1 Ion Channel in Open, Closed, and Two Mutated States.
J. Membr. Biol., 2014 Dec 2 , ().

56

Bloom S et al. Heterogeneous calretinin expression in the avian cochlear nucleus angularis.
J. Assoc. Res. Otolaryngol., 2014 Aug , 15 (603-20).

57

Zhu J et al. The Kv1.3 potassium channel is localized to the cis-Golgi and Kv1.6 is localized to the endoplasmic reticulum in rat astrocytes.
FEBS J., 2014 Aug , 281 (3433-45).

58

Graves TD et al. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Brain, 2014 Apr , 137 (1009-18).

59

Cioli C et al. Differences in human cortical gene expression match the temporal properties of large-scale functional networks.
PLoS ONE, 2014 , 9 (e115913).

60

Chen J et al. Neurological and cellular regulation of visceral hypersensitivity induced by chronic stress and colonic inflammation in rats.
Neuroscience, 2013 Sep 17 , 248 (469-78).

61

Lioudyno MI et al. Shaker-related potassium channels in the central medial nucleus of the thalamus are important molecular targets for arousal suppression by volatile general anesthetics.
J. Neurosci., 2013 Oct 9 , 33 (16310-22).

62

Gao D et al. Synthesis of the non-peptidic snail toxin 6-bromo-2-mercaptotryptamine dimer (BrMT)2, its lower and higher thio homologs and their ability to modulate potassium ion channels.
Bioorg. Med. Chem. Lett., 2013 Oct 15 , 23 (5503-6).

63

Tan SV et al. Episodic ataxia type 1 without episodic ataxia: the diagnostic utility of nerve excitability studies in individuals with KCNA1 mutations.
Dev Med Child Neurol, 2013 Oct , 55 (959-62).

64

Arjona FJ et al. Tissue-specific expression and in vivo regulation of zebrafish orthologues of mammalian genes related to symptomatic hypomagnesemia.
Pflugers Arch., 2013 Oct , 465 (1409-21).

65

D'Adamo MC et al. 5-HT2 receptors-mediated modulation of voltage-gated K+ channels and neurophysiopathological correlates.
Exp Brain Res, 2013 Oct , 230 (453-62).

66

Leanza L et al. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
Curr. Pharm. Des., 2013 May 16 , ().

67

Hao J et al. Kv1.1 channels act as mechanical brake in the senses of touch and pain.
Neuron, 2013 Mar 6 , 77 (899-914).

68

Orts DJ et al. Biochemical and electrophysiological characterization of two sea anemone type 1 potassium toxins from a geographically distant population of Bunodosoma caissarum.
Mar Drugs, 2013 Mar , 11 (655-79).

69

Feng J et al. Expression and characterization of a novel scorpine-like peptide Ev37, from the scorpion Euscorpiops validus.
Protein Expr. Purif., 2013 Mar , 88 (127-33).

70

Simeone TA et al. Loss of the Kv1.1 potassium channel promotes pathologic sharp waves and high frequency oscillations in in vitro hippocampal slices.
Neurobiol. Dis., 2013 Jun , 54 (68-81).

71

Lee SI et al. A null mutation of mouse Kcna10 causes significant vestibular and mild hearing dysfunction.
Hear. Res., 2013 Jun , 300 (1-9).

72

Sosanya NM et al. Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1.
J. Cell Biol., 2013 Jul 8 , 202 (53-69).

73

San-Cristobal P et al. Ankyrin-3 is a novel binding partner of the voltage-gated potassium channel Kv1.1 implicated in renal magnesium handling.
Kidney Int., 2013 Jul 31 , ().

74

Tomlinson SE et al. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
J. Neurol. Neurosurg. Psychiatr., 2013 Jan 24 , ().

75

Kurotani T et al. Pyramidal neurons in the superficial layers of rat retrosplenial cortex exhibit a late-spiking firing property.
Brain Struct Funct, 2013 Jan , 218 (239-54).

76

You MH et al. Voltage-gated K+ channels in adipogenic differentiation of bone marrow-derived human mesenchymal stem cells.
Acta Pharmacol. Sin., 2013 Jan , 34 (129-36).

77

Brewster DL et al. Expression of the voltage-gated potassium channel subunit Kv1.1 in embryonic zebrafish Mauthner cells.
Neurosci. Lett., 2013 Feb 28 , 539 (54-9).

78

Klassen TL et al. High-resolution molecular genomic autopsy reveals complex sudden unexpected death in epilepsy risk profile.
Epilepsia, 2013 Dec 24 , ().

79

Watanabe T et al. Coexpression of auxiliary Kvβ2 subunits with Kv1.1 channels is required for developmental acquisition of unique firing properties of zebrafish Mauthner cells.
J. Neurophysiol., 2013 Dec 11 , ().

80

Kyle BD et al. The Large Conductance, Calcium-activated K(+) (BK) Channel is regulated by Cysteine String Protein.
Sci Rep, 2013 Aug 15 , 3 (2447).

81

Al-Sabi A et al. Pharmacological characteristics of Kv1.1- and Kv1.2-containing channels are influenced by the stoichiometry and positioning of their α subunits.
Biochem. J., 2013 Aug 15 , 454 (101-8).

82

Krestel H et al. Differences between RNA and DNA due to RNA editing in temporal lobe epilepsy.
Neurobiol. Dis., 2013 Aug , 56 (66-73).

83

Kirchheim F et al. Regulation of action potential delays via voltage-gated potassium Kv1.1 channels in dentate granule cells during hippocampal epilepsy.
Front Cell Neurosci, 2013 , 7 (248).

84

Feng X et al. Hydrogen sulfide increases excitability through suppression of sustained potassium channel currents of rat trigeminal ganglion neurons.
Mol Pain, 2013 , 9 (4).

85

Rashid MH et al. A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmation.
PLoS ONE, 2013 , 8 (e78712).

86

Carlisle FA et al. Specific expression of Kcna10, Pxn and Odf2 in the organ of Corti.
Gene Expr. Patterns, 2012 May-Jun , 12 (172-9).

87

Brunetti O et al. Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature.
Neurobiol. Dis., 2012 Sep , 47 (310-21).

88

Dong W et al. A competition-based mechanism mediates developmental refinement of tectal neuron receptive fields.
J. Neurosci., 2012 Nov 21 , 32 (16872-9).

89

Wykes RC et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.
Sci Transl Med, 2012 Nov 21 , 4 (161ra152).

90

Pennington MW et al. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
FEBS Lett., 2012 Nov 16 , 586 (3996-4001).

91

Xie S et al. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
, 2012 May 8 , ().

92

Chen R et al. Engineering a potent and specific blocker of voltage-gated potassium channel Kv1.3, a target for autoimmune diseases.
Biochemistry, 2012 Mar 6 , 51 (1976-82).

93

Stehling EG et al. Looking over toxin-K(+) channel interactions. Clues from the structural and functional characterization of α-KTx toxin Tc32, a Kv1.3 channel blocker.
Biochemistry, 2012 Mar 6 , 51 (1885-94).

94

Wacker SJ et al. Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
, 2012 Mar 30 , ().

95

Ebner-Bennatan S et al. Multi-faceted modulation of K+ channels by protein tyrosine phosphatase epsilon tunes neuronal excitability.
, 2012 Jun 21 , ().

96

Jan LY et al. Voltage-gated potassium channels and the diversity of electrical signalling.
J. Physiol. (Lond.), 2012 Jun 1 , 590 (2591-9).

97

Yang SB et al. Kv1.1-dependent control of hippocampal neuron number as revealed by mosaic analysis with double markers.
J. Physiol. (Lond.), 2012 Jun 1 , 590 (2645-58).

98

Ison JR et al. Deficits in responding to brief noise offsets in Kcna1 -/- mice reveal a contribution of this gene to precise temporal processing seen previously only for stimulus onsets.
J. Assoc. Res. Otolaryngol., 2012 Jun , 13 (351-8).

99

Van Poucke M et al. Experimental validation of in silico predicted KCNA1, KCNA2, KCNA6 and KCNQ2 genes for association studies of peripheral nerve hyperexcitability syndrome in Jack Russell Terriers.
Neuromuscul. Disord., 2012 Jun , 22 (558-65).

100

Menegola M et al. The importance of immunohistochemical analyses in evaluating the phenotype of Kv channel knockout mice.
Epilepsia, 2012 Jun , 53 Suppl 1 (142-9).

101

Robbins CA et al. Kv1.1 and Kv1.2: Similar channels, different seizure models.
Epilepsia, 2012 Jun , 53 Suppl 1 (134-41).

102

Hocking JC et al. Neural activity and branching of embryonic retinal ganglion cell dendrites.
Mech. Dev., 2012 Jul , 129 (125-35).

103

Iwasaki S et al. Developmental changes in the expression of Κv1 potassium channels in rat vestibular ganglion cells.
Brain Res., 2012 Jan 6 , 1429 (29-35).

104

Ishida S et al. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
Brain Res., 2012 Jan 30 , 1435 (154-66).

105

Allen PD et al. Kcna1 gene deletion lowers the behavioral sensitivity of mice to small changes in sound location and increases asynchronous brainstem auditory evoked potentials but does not affect hearing thresholds.
J. Neurosci., 2012 Feb 15 , 32 (2538-43).

106

Li KX et al. Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy.
Nat. Neurosci., 2012 Feb , 15 (267-73).

107

Dwyer J et al. Resonance in neocortical neurons and networks.
Eur. J. Neurosci., 2012 Dec , 36 (3698-708).

108

Jeon WI et al. Effects of voltage-gated K+ channel blockers in gefitinib-resistant H460 non-small cell lung cancer cells.
Anticancer Res., 2012 Dec , 32 (5279-84).

109

Glasscock E et al. Transcompartmental reversal of single fibre hyperexcitability in juxtaparanodal Kv1.1-deficient vagus nerve axons by activation of nodal KCNQ channels.
J. Physiol. (Lond.), 2012 Aug 15 , 590 (3913-26).

110

Zhu J et al. Characterization of the Kv1.1 I262T and S342I mutations associated with episodic ataxia 1 with distinct phenotypes.
Arch. Biochem. Biophys., 2012 Aug 15 , 524 (99-105).

111

Rashid MH et al. Affinity and selectivity of ShK toxin for the Kv1 potassium channels from free energy simulations.
J Phys Chem B, 2012 Apr 26 , 116 (4812-22).

112

Huang CY et al. Co-expression of high-voltage-activated ion channels Kv3.4 and Cav1.2 in pioneer axons during pathfinding in the developing rat forebrain.
, 2012 Apr 2 , ().

113

Chen R et al. Structural basis of the selective block of Kv1.2 by maurotoxin from computer simulations.
PLoS ONE, 2012 , 7 (e47253).

114

Baloh RW Episodic ataxias 1 and 2.
Handb Clin Neurol, 2012 , 103 (595-602).

115

Yang XF et al. The antibody targeting the e314 Peptide of human kv1.3 pore region serves as a novel, potent and specific channel blocker.
PLoS ONE, 2012 , 7 (e36379).

116

Moreno C et al. Polyunsaturated Fatty acids modify the gating of kv channels.
Front Pharmacol, 2012 , 3 (163).

117

Leanza L et al. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
Curr. Med. Chem., 2012 , 19 (5394-404).

118

Jenkins PM et al. Subunit-dependent axonal trafficking of distinct alpha heteromeric potassium channel complexes.
J. Neurosci., 2011 Sep 14 , 31 (13224-35).

119

Fisahn A et al. Acoustic startle hypersensitivity in Mceph mice and its effect on hippocampal excitability.
Eur. J. Neurosci., 2011 Oct , 34 (1121-30).

120

Bildl W et al. Extending The Dynamic Range Of Label-Free Mass Spectrometric Quantification Of Affinity Purifications.
, 2011 Nov 8 , ().

121

Peters CJ et al. Mechanism of accelerated current decay caused by an episodic ataxia type-1-associated mutant in a potassium channel pore.
J. Neurosci., 2011 Nov 30 , 31 (17449-59).

122

Fulton S et al. Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow.
J. Biol. Chem., 2011 Mar 18 , 286 (9360-72).

123

Jang SH et al. Dendrotoxin-κ suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice.
J. Vet. Sci., 2011 Mar , 12 (35-40).

124

Imbrici P et al. Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.
Am. J. Physiol., Cell Physiol., 2011 Jun , 300 (C1314-22).

125

Camargos TS et al. The new kappa-KTx 2.5 from the scorpion Opisthacanthus cayaporum.
Peptides, 2011 Jul , 32 (1509-17).

126

Popratiloff A et al. Expression of glutamate receptors and potassium channels in vestibular nuclei neurons during development of signal processing.
J Vestib Res, 2011 Jan 1 , 21 (21-31).

127

Firth AL et al. Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels.
Pulm Circ, 2011 Jan 1 , 1 (48-71).

128

Jin L et al. Molecular mechanism of δ-dendrotoxin-potassium channel recognition explored by docking and molecular dynamic simulations.
J. Mol. Recognit., 2011 Jan , 24 (101-7).

129

Chen Z et al. ImKTx1, a new Kv1.3 channel blocker with a unique primary structure.
, 2011 Feb 9 , ().

130

Zhu S et al. Molecular diversity and functional evolution of scorpion potassium channel toxins.
Mol. Cell Proteomics, 2011 Feb , 10 (M110.002832).

131

Han S et al. ImKTx88, a novel selective Kv1.3 channel blocker derived from the scorpion Isometrus maculates.
Toxicon, 2011 Feb , 57 (348-55).

132

Roepke TK et al. KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium.
FASEB J., 2011 Dec , 25 (4264-73).

133

Streit AK et al. A-to-I RNA Editing Modulates the Pharmacology of Neuronal Ion Channels and Receptors.
Biochemistry Mosc., 2011 Aug , 76 (890-9).

134

Northcott PA et al. Medulloblastoma comprises four distinct molecular variants.
J. Clin. Oncol., 2011 Apr 10 , 29 (1408-14).

135

Leung YM et al. Voltage-gated K+ channels play a role in cAMP-stimulated neuritogenesis in mouse neuroblastoma N2A cells.
J. Cell. Physiol., 2011 Apr , 226 (1090-8).

136

Ma Z et al. Evidence for presence and functional effects of Kv1.1 channels in β-cells: general survey and results from mceph/mceph mice.
PLoS ONE, 2011 , 6 (e18213).

137

Deng YY et al. Role of microglia in the process of inflammation in the hypoxic developing brain.
Front Biosci (Schol Ed), 2011 , 3 (884-900).

138

Martel P et al. Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function.
PLoS ONE, 2011 , 6 (e20402).

139

Zironi I et al. Molecular remodeling of potassium channels in fibroblasts from centenarians: a marker of longevity?
Mech. Ageing Dev., 2010 Nov-Dec , 131 (674-81).

140

Wagner CA New roles for renal potassium channels.
J. Nephrol., 2010 Jan-Feb , 23 (5-8).

141

Cao XH et al. Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor.
J. Neurochem., 2010 Sep 1 , 114 (1460-75).

142

San-Cristobal P et al. Novel molecular pathways in renal Mg2+ transport: a guided tour along the nephron.
Curr. Opin. Nephrol. Hypertens., 2010 Sep , 19 (456-62).

143

Al-Sabi A et al. Arrangement of Kv1 alpha subunits dictates sensitivity to tetraethylammonium.
J. Gen. Physiol., 2010 Sep , 136 (273-82).

144

Devaux J The C-terminal domain of aIV-spectrin is crucial for KCNQ2 aggregation and excitability at nodes of Ranvier.
, 2010 Oct 20 , ().

145

Xie G et al. A new Kv1.2 channelopathy underlying cerebellar ataxia.
J. Biol. Chem., 2010 Oct 15 , 285 (32160-73).

146

Rajakulendran S et al. PAW31 Clinical and genetic spectrum of the episodic ataxias: the UK perspective.
J. Neurol. Neurosurg. Psychiatr., 2010 Nov , 81 (e32).

147

Tong H et al. Regulation of Kv channel expression and neuronal excitability in rat medial nucleus of the trapezoid body maintained in organotypic culture.
J. Physiol. (Lond.), 2010 May 1 , 588 (1451-68).

148

Rangaraju S et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
J. Biol. Chem., 2010 Mar 19 , 285 (9124-36).

149

Lang F et al. Significance of SGK1 in the regulation of neuronal function.
, 2010 Jun 7 , ().

150

Liu J et al. [Expression and properties of potassium channels in human mammary epithelial cell line MCF10A and its possible role in proliferation].
Sheng Li Xue Bao, 2010 Jun 25 , 62 (203-9).

151

Decher N et al. RNA editing modulates the binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium channels.
EMBO J., 2010 Jul 7 , 29 (2101-13).

152

Graves TD et al. Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.
Neurology, 2010 Jul 27 , 75 (367-72).

153

Usman H et al. Potassium channel regulator KCNRG regulates surface expression of Shaker-type potassium channels.
Biochem. Biophys. Res. Commun., 2010 Jan 15 , 391 (1301-5).

154

van der Wijst J et al. Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.
J. Biol. Chem., 2010 Jan 1 , 285 (171-8).

155

Koeberle PD et al. Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo.
Cell Death Differ., 2010 Jan , 17 (134-44).

156

Han Y et al. Functional ion channels in mouse cardiac c-kit+ cells.
, 2010 Feb 3 , ().

157

Utsunomiya I et al. Identification of amino acids in the pore region of Kv1.2 potassium channel that regulate its glycosylation and cell surface expression.
J. Neurochem., 2010 Feb , 112 (913-23).

158

Serratrice G et al. [Potassium channelopathies and Morvan's syndromes].
Bull. Acad. Natl. Med., 2010 Feb , 194 (391-406; discussion 406-7).

159

Tomlinson SE et al. Nerve excitability studies characterize KV1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.
Brain, 2010 Dec , 133 (3530-40).

160

Large R et al. Ionic Currents in Intimal Cultured Synoviocytes from the Rabbit.
, 2010 Aug 18 , ().

161

Gazula VR et al. Localization of Kv1.3 channels in presynaptic terminals of brainstem auditory neurons.
J. Comp. Neurol., 2010 Aug 15 , 518 (3205-20).

162

Gao B et al. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
, 2010 Aug 13 , ().

163

Glasscock E et al. Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy.
J. Neurosci., 2010 Apr 14 , 30 (5167-75).

164

Park WS et al. Patho-, physiological roles of voltage-dependent K+ channels in pulmonary arterial smooth muscle cells.
J Smooth Muscle Res, 2010 , 46 (89-105).

165

Heeroma JH et al. Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.
Dis Model Mech, 2009 Nov-Dec , 2 (612-9).

166

Mohapatra DP et al. Regulation of intrinsic excitability in hippocampal neurons by activity-dependent modulation of the KV2.1 potassium channel.
Channels (Austin), 2009 Jan-Feb , 3 (46-56).

167

Imbrici P et al. Contribution of the central hydrophobic residue in the PXP motif of voltage-dependent K+ channels to S6 flexibility and gating properties.
Channels (Austin), 2009 Jan-Feb , 3 (39-45).

168

Baraban SC et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice.
Proc. Natl. Acad. Sci. U.S.A., 2009 Sep 8 , 106 (15472-7).

169

Rajakulendran S et al. A patient with episodic ataxia and paramyotonia congenita due to mutations in KCNA1 and SCN4A.
Neurology, 2009 Sep 22 , 73 (993-5).

170

Papp F et al. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Toxicon, 2009 Sep 15 , 54 (379-89).

171

Fenoglio-Simeone K et al. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.
Epilepsy Behav, 2009 Sep , 16 (52-7).

172

Fenoglio-Simeone KA et al. Ketogenic diet treatment abolishes seizure periodicity and improves diurnal rhythmicity in epileptic Kcna1-null mice.
Epilepsia, 2009 Sep , 50 (2027-34).

173

Buckinx R et al. Morphological changes do not reflect biochemical and functional differentiation in OLN-93 oligodendroglial cells.
J. Neurosci. Methods, 2009 Oct 30 , 184 (1-9).

174

Sankaranarayanan K et al. Fast inactivation in potassium channels: an interplay of cytoplasmic domains.
Biochem. Biophys. Res. Commun., 2009 Oct 23 , 388 (490-5).

175

Sculptoreanu A et al. Neurokinins inhibit low threshold inactivating K+ currents in capsaicin responsive DRG neurons.
Exp. Neurol., 2009 Oct , 219 (562-73).

176

Shen QJ et al. Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons.
J. Neurosci. Res., 2009 Nov 1 , 87 (3153-60).

177

Dvir H et al. Bacterial expression of a eukaryotic membrane protein in fusion to various Mistic orthologs.
Protein Expr. Purif., 2009 Nov , 68 (28-33).

178

Feinshreiber L et al. Syntaxin modulates Kv1.1 through dual action on channel surface expression and conductance.
Biochemistry, 2009 May 19 , 48 (4109-14).

179

Damak M et al. Late onset hereditary episodic ataxia.
J. Neurol. Neurosurg. Psychiatr., 2009 May , 80 (566-8).

180

Jen JC et al. Familial episodic ataxia: a model for migrainous vertigo.
Ann. N. Y. Acad. Sci., 2009 May , 1164 (252-6).

181

Hsiao CF et al. Participation of Kv1 channels in control of membrane excitability and burst generation in mesencephalic V neurons.
J. Neurophysiol., 2009 Mar , 101 (1407-18).

182

Nekrasova OV et al. Recombinant Kv channels at the membrane of Escherichia coli bind specifically agitoxin2.
J Neuroimmune Pharmacol, 2009 Mar , 4 (83-91).

183

Shao M et al. Adaptation of chicken vestibular nucleus neurons to unilateral vestibular ganglionectomy.
Neuroscience, 2009 Jul 21 , 161 (988-1007).

184

Zhu J et al. The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and function.
Brain Res., 2009 Jan 28 , 1251 (16-29).

185

Shao M et al. Presynaptic and postsynaptic ion channel expression in vestibular nuclei neurons after unilateral vestibular deafferentation.
J Vestib Res, 2009 Jan , 19 (191-200).

186

Wu CY et al. Kv1.1 expression in microglia regulates production and release of proinflammatory cytokines, endothelins and nitric oxide.
Neuroscience, 2009 Feb 18 , 158 (1500-8).

187

Takacs Z et al. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Proc. Natl. Acad. Sci. U.S.A., 2009 Dec 29 , 106 (22211-6).

188

Lee SM et al. Down-regulation of delayed rectifier K+ channels in the hippocampus of seizure sensitive gerbils.
Brain Res. Bull., 2009 Dec 16 , 80 (433-42).

189

Prüss H et al. Age-dependent axonal expression of potassium channel proteins during development in mouse hippocampus.
, 2009 Dec 12 , ().

190

Kuenzel T et al. Increase of Kv3.1b expression in avian auditory brainstem neurons correlates with synaptogenesis in vivo and in vitro.
Brain Res., 2009 Dec 11 , 1302 (64-75).

191

Hofstetter C et al. Reduction of seizures by transplantation of embryonic GABAergic interneurons into Kv1.1 mutant mice.
Neurosurgery, 2009 Dec , 65 (N8-9).

192

Deng M et al. Jingzhaotoxin-IX, a novel gating modifier of both sodium and potassium channels from Chinese tarantula Chilobrachys jingzhao.
Neuropharmacology, 2009 Aug , 57 (77-87).

193

Kobayashi K et al. Perinatal exposure to PTU decreases expression of Arc, Homer 1, Egr 1 and Kcna 1 in the rat cerebral cortex and hippocampus.
Brain Res., 2009 Apr 6 , 1264 (24-32).

194

Demos MK et al. A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.
Mov. Disord., 2009 Apr 15 , 24 (778-82).

195

Glaudemans B et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia.
J. Clin. Invest., 2009 Apr , 119 (936-42).

196

Ellison DH The voltage-gated K+ channel subunit Kv1.1 links kidney and brain.
J. Clin. Invest., 2009 Apr , 119 (763-6).

197

Liu J et al. Molecular cloning and functional identification of a new K(+) channel blocker, LmKTx10, from the scorpion Lychas mucronatus.
Peptides, 2009 Apr , 30 (675-80).

198

Menteyne A et al. Predominant functional expression of Kv1.3 by activated microglia of the hippocampus after Status epilepticus.
PLoS ONE, 2009 , 4 (e6770).

199

Kapur J Is epilepsy a disease of synaptic transmission?
, 2008 Sep-Oct , 8 (139-41).

200

Shijin Y et al. Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch.
Peptides, 2008 Sep , 29 (1514-20).

201

Parodi J et al. Some effects of the venom of the Chilean spider Latrodectus mactans on endogenous ion-currents of Xenopus laevis oocytes.
Biochem. Biophys. Res. Commun., 2008 Oct 31 , 375 (571-5).

202

Duncan CE et al. Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action.
Psychiatr. Genet., 2008 Oct , 18 (226-39).

203

Abbas N et al. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Biochem. Biophys. Res. Commun., 2008 Nov 21 , 376 (525-30).

204

Punke MA et al. Lipophilic and stereospecific interactions of amino-amide local anesthetics with human Kv1.1 channels.
Anesthesiology, 2008 Nov , 109 (895-904).

205

Yin SJ et al. Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels.
J. Proteome Res., 2008 Nov , 7 (4890-7).

206

Savvaki M et al. Impairment of learning and memory in TAG-1 deficient mice associated with shorter CNS internodes and disrupted juxtaparanodes.
Mol. Cell. Neurosci., 2008 Nov , 39 (478-90).

207

Goldberg EM et al. K+ channels at the axon initial segment dampen near-threshold excitability of neocortical fast-spiking GABAergic interneurons.
Neuron, 2008 May 8 , 58 (387-400).

208

Ogawa Y et al. Postsynaptic density-93 clusters Kv1 channels at axon initial segments independently of Caspr2.
J. Neurosci., 2008 May 28 , 28 (5731-9).

209

Zarrabi M et al. The investigation of interactions of kappa-Hefutoxin1 with the voltage-gated potassium channels: a computational simulation.
Proteins, 2008 May 15 , 71 (1441-9).

210

Reissner KJ et al. Aplysia synapse associated protein (APSAP): identification, characterization, and selective interactions with Shaker-type potassium channels.
J. Neurochem., 2008 May , 105 (1006-18).

211

Rusznák Z et al. Voltage-gated potassium channel (Kv) subunits expressed in the rat cochlear nucleus.
J. Histochem. Cytochem., 2008 May , 56 (443-65).

212

Pan Y et al. Functional coupling between the Kv1.1 channel and aldoketoreductase Kvbeta1.
J. Biol. Chem., 2008 Mar 28 , 283 (8634-42).

213

Lü Q et al. Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators).
Bioorg. Med. Chem., 2008 Mar 15 , 16 (3067-75).

214

Utsunomiya I et al. Expression and localization of Kv1 potassium channels in rat dorsal and ventral spinal roots.
Exp. Neurol., 2008 Mar , 210 (51-8).

215

Shook SJ et al. Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.
Muscle Nerve, 2008 Mar , 37 (399-402).

216

Abdel-Mottaleb Y et al. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
Toxicon, 2008 Jun 15 , 51 (1424-30).

217

Oertel D et al. In the ventral cochlear nucleus Kv1.1 and subunits of HCN1 are colocalized at surfaces of neurons that have low-voltage-activated and hyperpolarization-activated conductances.
Neuroscience, 2008 Jun 12 , 154 (77-86).

218

Nishimoto Y et al. Determination of editors at the novel A-to-I editing positions.
Neurosci. Res., 2008 Jun , 61 (201-6).

219

Han S et al. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.
J. Biol. Chem., 2008 Jul 4 , 283 (19058-65).

220

Diani E et al. Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins.
Epilepsy Res., 2008 Jul , 80 (1-8).

221

Beeton C et al. The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
J. Biol. Chem., 2008 Jan 11 , 283 (988-97).

222

Salom JB et al. Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil.
Eur. J. Pharmacol., 2008 Feb 26 , 581 (138-47).

223

Jen JC Recent advances in the genetics of recurrent vertigo and vestibulopathy.
Curr. Opin. Neurol., 2008 Feb , 21 (3-7).

224

Lorincz A et al. Cell-type-dependent molecular composition of the axon initial segment.
J. Neurosci., 2008 Dec 31 , 28 (14329-40).

225

Imbrici P et al. A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.
Neuroscience, 2008 Dec 2 , 157 (577-87).

226

Allen PD et al. Kv1.1 channel subunits are not necessary for high temporal acuity in behavioral and electrophysiological gap detection.
Hear. Res., 2008 Dec , 246 (52-8).

227

Park KS et al. Diversity of ion channels in human bone marrow mesenchymal stem cells from amyotrophic lateral sclerosis patients.
Korean J. Physiol. Pharmacol., 2008 Dec , 12 (337-42).

228

González-Pérez V et al. Slow inactivation in Shaker K channels is delayed by intracellular tetraethylammonium.
J. Gen. Physiol., 2008 Dec , 132 (633-50).

229

Heaps CL et al. Effects of exercise training and hypercholesterolemia on adenosine activation of voltage-dependent K+ channels in coronary arterioles.
J. Appl. Physiol., 2008 Dec , 105 (1761-71).

230

Hu CL et al. Kv 1.1 is associated with neuronal apoptosis and modulated by protein kinase C in the rat cerebellar granule cell.
J. Neurochem., 2008 Aug , 106 (1125-37).

231

Yuan CH et al. Discovery of a distinct superfamily of Kunitz-type toxin (KTT) from tarantulas.
PLoS ONE, 2008 , 3 (e3414).

232

Zhu J et al. Kv1 potassium channel C-terminus constant HRETE region: arginine substitution affects surface protein level and conductance level of subfamily members differentially.
Mol. Membr. Biol., 2007 May-Jun , 24 (194-205).

233

Brew HM et al. Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons.
J. Neurophysiol., 2007 Sep , 98 (1501-25).

234

Yang Q et al. Kv1.1/1.2 channels are downstream effectors of nitric oxide on synaptic GABA release to preautonomic neurons in the paraventricular nucleus.
Neuroscience, 2007 Oct 26 , 149 (315-27).

235

Jen JC et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment.
Brain, 2007 Oct , 130 (2484-93).

236

Bai X et al. Electrophysiological properties of human adipose tissue-derived stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1539-50).

237

Wenzel HJ et al. Structural consequences of Kcna1 gene deletion and transfer in the mouse hippocampus.
Epilepsia, 2007 Nov , 48 (2023-46).

238

Chi XX et al. Manipulation of the potassium channel Kv1.1 and its effect on neuronal excitability in rat sensory neurons.
J. Neurophysiol., 2007 Nov , 98 (2683-92).

239

Watanabe I et al. The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials.
Brain Res., 2007 May 4 , 1144 (1-18).

240

Punke MA et al. Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels.
Anesth. Analg., 2007 May , 104 (1256-64, tables of contents).

241

Vacher H et al. Regulation of Kv1 channel trafficking by the mamba snake neurotoxin dendrotoxin K.
FASEB J., 2007 Mar , 21 (906-14).

242

Kim DS et al. Seizure activity affects neuroglial Kv1 channel immunoreactivities in the gerbil hippocampus.
Brain Res., 2007 Jun 2 , 1151 (172-87).

243

Michaelevski I et al. Interaction of syntaxin with a single Kv1.1 channel: a possible mechanism for modulating neuronal excitability.
Pflugers Arch., 2007 Jun , 454 (477-94).

244

Shoudai K et al. Effects of various K+ channel blockers on spontaneous glycine release at rat spinal neurons.
Brain Res., 2007 Jul 9 , 1157 (11-22).

245

Höltje M et al. Differential distribution of voltage-gated potassium channels Kv 1.1-Kv1.6 in the rat retina during development.
J. Neurosci. Res., 2007 Jan , 85 (19-33).

246

Falace A et al. Inherited neuromyotonia: a clinical and genetic study of a family.
Neuromuscul. Disord., 2007 Jan , 17 (23-7).

247

Rivera J et al. The role of Kif5B in axonal localization of Kv1 K(+) channels.
Eur. J. Neurosci., 2007 Jan , 25 (136-46).

248

Imbrici P et al. Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.
Am. J. Physiol., Cell Physiol., 2007 Feb , 292 (C778-87).

249

Glasscock E et al. Masking epilepsy by combining two epilepsy genes.
Nat. Neurosci., 2007 Dec , 10 (1554-8).

250

Rampino T et al. KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells.
Growth Factors, 2007 Dec , 25 (382-91).

251

Park KS et al. Functional expression of ion channels in mesenchymal stem cells derived from umbilical cord vein.
Stem Cells, 2007 Aug , 25 (2044-52).

252

Sokolov MV et al. Concatemers of brain Kv1 channel alpha subunits that give similar K+ currents yield pharmacologically distinguishable heteromers.
Neuropharmacology, 2007 Aug , 53 (272-82).

253

Rajakulendran S et al. Episodic ataxia type 1: a neuronal potassium channelopathy.
, 2007 Apr , 4 (258-66).

254

Bozzola E et al. [Spinocerebellar ataxias in infancy: pathogenesis of potassium and calcium channels' diseases, clinical features and therapeutical approach]
Minerva Pediatr., 2007 Apr , 59 (149-56).

255

Westman E et al. Carbamazepine treatment recovered low N-acetylaspartate+N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph).
Neurobiol. Dis., 2007 Apr , 26 (221-8).

256

Few WP et al. Sex differences in and hormonal regulation of Kv1 potassium channel gene expression in the electric organ: molecular control of a social signal.
Dev Neurobiol, 2007 Apr , 67 (535-49).

257

Chen H et al. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.
Neurogenetics, 2007 Apr , 8 (131-5).

258

Almgren M et al. Lack of potassium channel induces proliferation and survival causing increased neurogenesis and two-fold hippocampus enlargement.
, 2007 , 17 (292-304).

259

Persson AS et al. Kv1.1 null mice have enlarged hippocampus and ventral cortex.
, 2007 , 8 (10).

260

Mondal S et al. In silico detection of binding mode of J-superfamily conotoxin pl14a with Kv1.6 channel.
In Silico Biol. (Gedrukt), 2007 , 7 (175-86).

261

Hoegg S et al. Phylogenomic analyses of KCNA gene clusters in vertebrates: why do gene clusters stay intact?
BMC Evol. Biol., 2007 , 7 (139).

262

Gittelman JX et al. Kv1.1-containing channels are critical for temporal precision during spike initiation.
J. Neurophysiol., 2006 Sep , 96 (1203-14).

263

Raab-Graham KF et al. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites.
Science, 2006 Oct 6 , 314 (144-8).

264

Saito M et al. Two opposing roles of 4-AP-sensitive K+ current in initiation and invasion of spikes in rat mesencephalic trigeminal neurons.
J. Neurophysiol., 2006 Oct , 96 (1887-901).

265

Clark E et al. Kv1.1 takes a deTOR from the axon to the dendrite.
Neuron, 2006 Nov 9 , 52 (399-401).

266

Abdel-Mottaleb Y et al. The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
FEBS Lett., 2006 Nov 13 , 580 (6254-8).

267

Beraud E et al. Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy.
Ann. Neurol., 2006 Nov , 60 (586-96).

268

Fantozzi I et al. Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells.
Am. J. Physiol. Lung Cell Mol. Physiol., 2006 Nov , 291 (L993-1004).

269

Wu WK et al. Involvement of Kv1.1 and Nav1.5 in proliferation of gastric epithelial cells.
J. Cell. Physiol., 2006 May , 207 (437-44).

270

Kaczmarek LK Policing the ball: a new potassium channel subunit determines inactivation rate.
Neuron, 2006 Mar 2 , 49 (642-4).

271

Schulte U et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1.
Neuron, 2006 Mar 2 , 49 (697-706).

272

Guan D et al. Expression and biophysical properties of Kv1 channels in supragranular neocortical pyramidal neurones.
J. Physiol. (Lond.), 2006 Mar 1 , 571 (371-89).

273

Sinha K et al. Functional changes in genetically dysmyelinated spinal cord axons of shiverer mice: role of juxtaparanodal Kv1 family K+ channels.
J. Neurophysiol., 2006 Mar , 95 (1683-95).

274

Kleopa KA et al. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
Brain, 2006 Jun , 129 (1570-84).

275

Poujois A et al. Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene.
J. Neurol., 2006 Jul , 253 (957-9).

276

Abdel-Mottaleb Y et al. A novel toxin from the venom of the scorpion Tityus trivittatus, is the first member of a new alpha-KTX subfamily.
FEBS Lett., 2006 Jan 23 , 580 (592-6).

277

Falk T et al. Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture.
J. Comp. Neurol., 2006 Jan 10 , 494 (275-89).

278

Yuan LL et al. Acceleration of K+ channel inactivation by MEK inhibitor U0126.
Am. J. Physiol., Cell Physiol., 2006 Jan , 290 (C165-71).

279

Pirisino R et al. 4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels.
Br. J. Pharmacol., 2006 Jan , 147 (218-24).

280

Bortone DS et al. Developmental time course of potassium channel expression in the rat cochlear nucleus.
Hear. Res., 2006 Jan , 211 (114-25).

281

Furuzono S et al. Inherent pacemaker function of duodenal GIST.
Eur. J. Cancer, 2006 Jan , 42 (243-8).

282

Baker KA et al. NMR-derived dynamic aspects of N-type inactivation of a Kv channel suggest a transient interaction with the T1 domain.
Biochemistry, 2006 Feb 14 , 45 (1663-72).

283

Imbrici P et al. Episodic ataxia type 1 mutations in the KCNA1 gene impair the fast inactivation properties of the human potassium channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2.
Eur. J. Neurosci., 2006 Dec , 24 (3073-83).

284

Balana B et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells.
Cell Res., 2006 Dec , 16 (949-60).

285

Smith GT et al. Distribution of Kv1-like potassium channels in the electromotor and electrosensory systems of the weakly electric fish Apteronotus leptorhynchus.
J. Neurobiol., 2006 Aug , 66 (1011-31).

286

Sah P Canonical organization of opioid modulation of nociceptive circuits. Focus on "mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/Kv1.2 channels".
J. Neurophysiol., 2006 Apr , 95 (2029-30).

287

Finnegan TF et al. Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels.
J. Neurophysiol., 2006 Apr , 95 (2032-41).

288

Sankaranarayanan K et al. N type rapid inactivation in human Kv1.4 channels: functional role of a putative C-terminal helix.
Mol. Membr. Biol., 2005 Sep-Oct , 22 (389-400).

289

Kourrich S et al. Transient hippocampal down-regulation of Kv1.1 subunit mRNA during associative learning in rats.
Learn. Mem., 2005 Sep-Oct , 12 (511-9).

290

Li X et al. Involvement of Scn1b and Kcna1 ion channels in audiogenic seizures and PTZ-induced epilepsy.
Epilepsy Res., 2005 Aug-Sep , 66 (155-63).

291

Sutachan JJ et al. Effects of Kv1.1 channel glycosylation on C-type inactivation and simulated action potentials.
Brain Res., 2005 Oct 5 , 1058 (30-43).

292

Chagot B et al. An unusual fold for potassium channel blockers: NMR structure of three toxins from the scorpion Opisthacanthus madagascariensis.
Biochem. J., 2005 May 15 , 388 (263-71).

293

Barfield JP et al. The effects of putative K+ channel blockers on volume regulation of murine spermatozoa.
Biol. Reprod., 2005 May , 72 (1275-81).

294

Yan L et al. Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels.
Mol. Pharmacol., 2005 May , 67 (1513-21).

295

Kline DD et al. Kv1.1 deletion augments the afferent hypoxic chemosensory pathway and respiration.
J. Neurosci., 2005 Mar 30 , 25 (3389-99).

296

Srairi-Abid N et al. A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels.
Biochem. J., 2005 Jun 1 , 388 (455-64).

297

Wang J et al. Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery.
Am. J. Physiol. Lung Cell Mol. Physiol., 2005 Jun , 288 (L1049-58).

298

Jung DK et al. Age-related changes in the distribution of Kv1.1 and Kv3.1 in rat cochlear nuclei.
Neurol. Res., 2005 Jun , 27 (436-40).

299

Vydyanathan A et al. A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons.
J. Neurophysiol., 2005 Jun , 93 (3401-9).

300

Eftekharpour E et al. Structural and functional alterations of spinal cord axons in adult Long Evans Shaker (LES) dysmyelinated rats.
Exp. Neurol., 2005 Jun , 193 (334-49).

301

Gilquin B et al. A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpions.
J. Biol. Chem., 2005 Jul 22 , 280 (27093-102).

302

Mobasheri A et al. Quantitative analysis of voltage-gated potassium currents from primary equine (Equus caballus) and elephant (Loxodonta africana) articular chondrocytes.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005 Jul , 289 (R172-80).

303

Shumilina E et al. Deranged Kv channel regulation in fibroblasts from mice lacking the serum and glucocorticoid inducible kinase SGK1.
J. Cell. Physiol., 2005 Jul , 204 (87-98).

304

Hernández-González EO et al. Absence of Dp71 in mdx3cv mouse spermatozoa alters flagellar morphology and the distribution of ion channels and nNOS.
J. Cell. Sci., 2005 Jan 1 , 118 (137-45).

305

Pál B et al. Voltage-gated and background K+ channel subunits expressed by the bushy cells of the rat cochlear nucleus.
Hear. Res., 2005 Jan , 199 (57-70).

306

Devaux JJ et al. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA.
J. Neurosci., 2005 Feb 9 , 25 (1470-80).

307

Plane F et al. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
Circ. Res., 2005 Feb 4 , 96 (216-24).

308

Chung YH et al. Immunohistochemical study on the distribution of the voltage-gated potassium channels in the gerbil cerebellum.
Neurosci. Lett., 2005 Feb 1 , 374 (58-62).

309

Liu HL et al. Homology models of the tetramerization domain of six eukaryotic voltage-gated potassium channels Kv1.1-Kv1.6.
J. Biomol. Struct. Dyn., 2005 Feb , 22 (387-98).

310

Léoni AL et al. Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle.
Physiol. Genomics, 2005 Dec 14 , 24 (4-12).

311

Herrmann A et al. [Episodic ataxias]
Tidsskr. Nor. Laegeforen., 2005 Aug 11 , 125 (2005-7).

312

Chen G et al. Involvement of kv1 potassium channels in spreading acidification and depression in the cerebellar cortex.
J. Neurophysiol., 2005 Aug , 94 (1287-98).

313

Gubitosi-Klug RA et al. The human Kv1.1 channel is palmitoylated, modulating voltage sensing: Identification of a palmitoylation consensus sequence.
Proc. Natl. Acad. Sci. U.S.A., 2005 Apr 26 , 102 (5964-8).

314

Beeton C et al. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
Mol. Pharmacol., 2005 Apr , 67 (1369-81).

315

Bagdány M et al. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Mol. Pharmacol., 2005 Apr , 67 (1034-44).

316

Persson AS et al. A truncated Kv1.1 protein in the brain of the megencephaly mouse: expression and interaction.
, 2005 , 6 (65).

317

Bähring R et al. Differential modulation of Kv1 channel-mediated currents by co-expression of Kvbeta3 subunit in a mammalian cell-line.
Mol. Membr. Biol., 2004 Jan-Feb , 21 (19-25).

318

Manganas LN et al. Calnexin regulates mammalian Kv1 channel trafficking.
Biochem. Biophys. Res. Commun., 2004 Sep 17 , 322 (577-84).

319

Wang W Renal potassium channels: recent developments.
Curr. Opin. Nephrol. Hypertens., 2004 Sep , 13 (549-55).

320

Cusimano A et al. An episodic ataxia type-1 mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+.
FEBS Lett., 2004 Oct 8 , 576 (237-44).

321

Jow F et al. Functional coupling of intracellular calcium and inactivation of voltage-gated Kv1.1/Kvbeta1.1 A-type K+ channels.
Proc. Natl. Acad. Sci. U.S.A., 2004 Oct 26 , 101 (15535-40).

322

Kauferstein S et al. Novel conopeptides of the I-superfamily occur in several clades of cone snails.
Toxicon, 2004 Oct , 44 (539-48).

323

Kinali M et al. Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia.
Neuromuscul. Disord., 2004 Oct , 14 (689-93).

324

Arroyo EJ et al. Acute demyelination disrupts the molecular organization of peripheral nervous system nodes.
J. Comp. Neurol., 2004 Nov 22 , 479 (424-34).

325

Wang Y et al. Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat.
J. Physiol. (Lond.), 2004 Nov 15 , 561 (65-90).

326

Piwowarski T et al. Molecular cloning and partial functional characterization of Tsha3--a novel modulatory potassium channel alpha-subunit of trout CNS.
Brain Res. Mol. Brain Res., 2004 May 19 , 124 (124-33).

327

Liu HL et al. A set of homology models of pore loop domain of six eukaryotic voltage-gated potassium channels Kv1.1-Kv1.6.
Proteins, 2004 May 15 , 55 (558-67).

328

Serratrice J Myokimia and potassium channel gene Kv1.1.
Acta Myol, 2004 May , 23 (VI).

329

Pirisino R et al. Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype.
Br. J. Pharmacol., 2004 May , 142 (381-9).

330

Watanabe I et al. Glycosylation affects the protein stability and cell surface expression of Kv1.4 but Not Kv1.1 potassium channels. A pore region determinant dictates the effect of glycosylation on trafficking.
J. Biol. Chem., 2004 Mar 5 , 279 (8879-85).

331

Shen W et al. Kv1.2-containing K+ channels regulate subthreshold excitability of striatal medium spiny neurons.
J. Neurophysiol., 2004 Mar , 91 (1337-49).

332

Speake T et al. Kv1.1 and Kv1.3 channels contribute to the delayed-rectifying K+ conductance in rat choroid plexus epithelial cells.
Am. J. Physiol., Cell Physiol., 2004 Mar , 286 (C611-20).

333

Jäger H et al. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Toxicon, 2004 Jun 15 , 43 (951-60).

334

Ferber M et al. Identification of a mammalian target of kappaM-conotoxin RIIIK.
Toxicon, 2004 Jun 15 , 43 (915-21).

335

Wang L et al. Identification of a Kv3.4 channel in corneal epithelial cells.
Invest. Ophthalmol. Vis. Sci., 2004 Jun , 45 (1796-803).

336

Vennekamp J et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Mol. Pharmacol., 2004 Jun , 65 (1364-74).

337

Zhang ZH et al. Disinactivation of N-type inactivation of voltage-gated K channels by an erbstatin analogue.
J. Biol. Chem., 2004 Jul 9 , 279 (29226-30).

338

Mouhat S et al. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Biochem. J., 2004 Jan 1 , 377 (25-36).

339

Li H et al. Selective elimination of I(K,slow1) in mouse ventricular myocytes expressing a dominant negative Kv1.5alpha subunit.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jan , 286 (H319-28).

340

Barnes-Davies M et al. Kv1 currents mediate a gradient of principal neuron excitability across the tonotopic axis in the rat lateral superior olive.
Eur. J. Neurosci., 2004 Jan , 19 (325-33).

341

Kodirov SA et al. Attenuation of I(K,slow1) and I(K,slow2) in Kv1/Kv2DN mice prolongs APD and QT intervals but does not suppress spontaneous or inducible arrhythmias.
Am. J. Physiol. Heart Circ. Physiol., 2004 Jan , 286 (H368-74).

342

Duzhyy DE et al. Cloning and developmental expression of Shaker potassium channels in the cochlea of the chicken.
Brain Res. Mol. Brain Res., 2004 Feb 5 , 121 (70-85).

343

Lu Y et al. Activity-dependent regulation of the potassium channel subunits Kv1.1 and Kv3.1.
J. Comp. Neurol., 2004 Feb 23 , 470 (93-106).

344

Karimi-Abdolrezaee S et al. Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma.
Eur. J. Neurosci., 2004 Feb , 19 (577-89).

345

Regaya I et al. Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins.
J. Biol. Chem., 2004 Dec 31 , 279 (55690-6).

346

Harvey AL et al. Dendrotoxins: structure-activity relationships and effects on potassium ion channels.
Curr. Med. Chem., 2004 Dec , 11 (3065-72).

347

Lee H et al. A novel mutation in KCNA1 causes episodic ataxia without myokymia.
Hum. Mutat., 2004 Dec , 24 (536).

348

Toledo-Rodriguez M et al. Correlation maps allow neuronal electrical properties to be predicted from single-cell gene expression profiles in rat neocortex.
Cereb. Cortex, 2004 Dec , 14 (1310-27).

349

Blaine JT et al. Carboxyl tail region of the Kv2.2 subunit mediates novel developmental regulation of channel density.
J. Neurophysiol., 2004 Dec , 92 (3446-54).

350

Fukui I et al. Tonotopic gradients of membrane and synaptic properties for neurons of the chicken nucleus magnocellularis.
J. Neurosci., 2004 Aug 25 , 24 (7514-23).

351

Fry M et al. Properties of Xenopus Kv1.10 channels expressed in HEK293 cells.
J. Neurobiol., 2004 Aug , 60 (227-35).

352

Liu HL et al. Molecular docking of the scorpion toxin Tc1 to the structural model of the voltage-gated potassium channel Kv1.1 from human Homo sapiens.
J. Biomol. Struct. Dyn., 2004 Apr , 21 (639-50).

353

Escobar LI et al. A voltage-gated K(+) current in renal inner medullary collecting duct cells.
Am. J. Physiol., Cell Physiol., 2004 Apr , 286 (C965-74).

354

Arai H et al. Modulation of a feeding neural circuit by microinjection of K+ channel expression genes into a single identified neuron in Aplysia kurodai.
Zool. Sci., 2004 Apr , 21 (369-73).

355

Klein A et al. Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy.
Neuropediatrics, 2004 Apr , 35 (147-9).

356

Mahjoubi-Boubaker B et al. Kbot1, a three disulfide bridges toxin from Buthus occitanus tunetanus venom highly active on both SK and Kv channels.
Peptides, 2004 Apr , 25 (637-45).

357

Yang EK et al. Altered expression of potassium channel subunit mRNA and alpha-dendrotoxin sensitivity of potassium currents in rat dorsal root ganglion neurons after axotomy.
Neuroscience, 2004 , 123 (867-74).

358

Vargas RA et al. Bufo marinus oocytes as a model for ion channel protein expression and functional characterization for electrophysiological studies.
Cell. Physiol. Biochem., 2004 , 14 (197-202).

359

Grunnet M et al. The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia.
Biochim. Biophys. Acta, 2003 Sep 22 , 1616 (85-94).

360

Albarwani S et al. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels.
J. Physiol. (Lond.), 2003 Sep 15 , 551 (751-63).

361

Lee AL et al. Potassium channel gene therapy can prevent neuron death resulting from necrotic and apoptotic insults.
J. Neurochem., 2003 Sep , 86 (1079-88).

362

Grunnet M et al. KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.
Biophys. J., 2003 Sep , 85 (1525-37).

363

M'Barek S et al. Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels.
Eur. J. Biochem., 2003 Sep , 270 (3583-92).

364

Kopp-Scheinpflug C et al. Decreased temporal precision of auditory signaling in Kcna1-null mice: an electrophysiological study in vivo.
J. Neurosci., 2003 Oct 8 , 23 (9199-207).

365

Wang GX et al. Functional effects of novel anti-ClC-3 antibodies on native volume-sensitive osmolyte and anion channels in cardiac and smooth muscle cells.
Am. J. Physiol. Heart Circ. Physiol., 2003 Oct , 285 (H1453-63).

366

Nie DY et al. Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization.
EMBO J., 2003 Nov 3 , 22 (5666-78).

367

Zhu J et al. Trafficking of Kv1.4 potassium channels: interdependence of a pore region determinant and a cytoplasmic C-terminal VXXSL determinant in regulating cell-surface trafficking.
Biochem. J., 2003 Nov 1 , 375 (761-8).

368

Thornhill WB et al. Molecular cloning and expression of a Kv1.1-like potassium channel from the electric organ of Electrophorus electricus.
J. Membr. Biol., 2003 Nov 1 , 196 (1-8).

369

Leung YM et al. Syntaxin 1A binds to the cytoplasmic C terminus of Kv2.1 to regulate channel gating and trafficking.
J. Biol. Chem., 2003 May 9 , 278 (17532-8).

370

Winklhofer M et al. Analysis of phosphorylation-dependent modulation of Kv1.1 potassium channels.
Neuropharmacology, 2003 May , 44 (829-42).

371

Huys I et al. Evidence for a function-specific mutation in the neurotoxin, parabutoxin 3.
Eur. J. Neurosci., 2003 May , 17 (1786-92).

372

Dhawan R et al. BTK-2, a new inhibitor of the Kv1.1 potassium channel purified from Indian scorpion Buthus tamulus.
FEBS Lett., 2003 Mar 27 , 539 (7-13).

373

Beeton C et al. A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes.
J. Biol. Chem., 2003 Mar 14 , 278 (9928-37).

374

Ghelardini C et al. Antisense knockdown of the Shaker-like Kv1.1 gene abolishes the central stimulatory effects of amphetamines in mice and rats.
Neuropsychopharmacology, 2003 Jun , 28 (1096-105).

375

Nilsson J et al. Local anesthetic block of Kv channels: role of the S6 helix and the S5-S6 linker for bupivacaine action.
Mol. Pharmacol., 2003 Jun , 63 (1417-29).

376

Imbrici P et al. Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels.
Pflugers Arch., 2003 Jun , 446 (373-9).

377

Lee SY et al. Adult alveolar epithelial cells express multiple subtypes of voltage-gated K+ channels that are located in apical membrane.
Am. J. Physiol., Cell Physiol., 2003 Jun , 284 (C1614-24).

378

Popratiloff A et al. Developmental change in expression and subcellular localization of two shaker-related potassium channel proteins (Kv1.1 and Kv1.2) in the chick tangential vestibular nucleus.
J. Comp. Neurol., 2003 Jul 7 , 461 (466-82).

379

Zhang ZH et al. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Brain Res. Mol. Brain Res., 2003 Jul 4 , 115 (29-38).

380

Rosenberger MH et al. Expression of the Kv1.1 ion channel subunit in the auditory brainstem of the big brown bat, Eptesicus fuscus.
J. Comp. Neurol., 2003 Jul 14 , 462 (101-20).

381

Zhu J et al. Heteromeric Kv1 potassium channel expression: amino acid determinants involved in processing and trafficking to the cell surface.
J. Biol. Chem., 2003 Jul 11 , 278 (25558-67).

382

Watanabe I et al. Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism.
J. Physiol. (Lond.), 2003 Jul 1 , 550 (51-66).

383

Dodson PD et al. Presynaptic rat Kv1.2 channels suppress synaptic terminal hyperexcitability following action potential invasion.
J. Physiol. (Lond.), 2003 Jul 1 , 550 (27-33).

384

Kauferstein S et al. A novel conotoxin inhibiting vertebrate voltage-sensitive potassium channels.
Toxicon, 2003 Jul , 42 (43-52).

385

Vianna-Jorge R et al. Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system.
Br. J. Pharmacol., 2003 Jan , 138 (57-62).

386

Coma M et al. Impaired voltage-gated K+ channel expression in brain during experimental cancer cachexia.
FEBS Lett., 2003 Feb 11 , 536 (45-50).

387

Castle NA et al. Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channels.
Mol. Pharmacol., 2003 Feb , 63 (409-18).

388

Zhou J et al. Regional upregulation of Kv2.1-encoded current, IK,slow2, in Kv1DN mice is abolished by crossbreeding with Kv2DN mice.
Am. J. Physiol. Heart Circ. Physiol., 2003 Feb , 284 (H491-500).

389

Beekwilder JP et al. Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p-aminobenzoate, a promising anesthetic for the treatment of chronic pain.
J. Pharmacol. Exp. Ther., 2003 Feb , 304 (531-8).

390

Ebner TJ et al. Spreading acidification and depression in the cerebellar cortex.
, 2003 Feb , 9 (37-45).

391

Lopantsev V et al. Hyperexcitability of CA3 pyramidal cells in mice lacking the potassium channel subunit Kv1.1.
Epilepsia, 2003 Dec , 44 (1506-12).

392

Petersson S et al. Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly.
Eur. J. Neurosci., 2003 Dec , 18 (3231-40).

393

Kodirov SA et al. Long-term restitution of 4-aminopyridine-sensitive currents in Kv1DN ventricular myocytes using adeno-associated virus-mediated delivery of Kv1.5.
FEBS Lett., 2003 Aug 28 , 550 (74-8).

394

Brew HM et al. Hyperexcitability and reduced low threshold potassium currents in auditory neurons of mice lacking the channel subunit Kv1.1.
J. Physiol. (Lond.), 2003 Apr 1 , 548 (1-20).

395

Hajdu P et al. Drug- and mutagenesis-induced changes in the selectivity filter of a cardiac two-pore background K+ channel.
Cardiovasc. Res., 2003 Apr 1 , 58 (46-54).

396

Herson PS et al. A mouse model of episodic ataxia type-1.
Nat. Neurosci., 2003 Apr , 6 (378-83).

397

Jiang X et al. Prostaglandin E2 inhibits the potassium current in sensory neurons from hyperalgesic Kv1.1 knockout mice.
Neuroscience, 2003 , 119 (65-72).

398

Michaelevski I et al. Modulation of a brain voltage-gated K+ channel by syntaxin 1A requires the physical interaction of Gbetagamma with the channel.
J. Biol. Chem., 2002 Sep 20 , 277 (34909-17).

399

Varshney A et al. Modulation of voltage sensitivity by N-terminal cytoplasmic residues in human Kv1.2 channels.
Eur. Biophys. J., 2002 Sep , 31 (365-72).

400

Matthias K et al. Modulation of voltage-gated K(+) channels Kv11 and Kv1 4 by forskolin.
Neuropharmacology, 2002 Sep , 43 (444-9).

401

Jiang B et al. Endogenous Kv channels in human embryonic kidney (HEK-293) cells.
Mol. Cell. Biochem., 2002 Sep , 238 (69-79).

402

Liu QH et al. Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation.
J. Exp. Med., 2002 Oct 7 , 196 (897-909).

403

Gilquin B et al. Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockers.
J. Biol. Chem., 2002 Oct 4 , 277 (37406-13).

404

Pollock NS et al. Expression of voltage-dependent potassium channels in the developing visual system of Xenopus laevis.
J. Comp. Neurol., 2002 Oct 28 , 452 (381-91).

405

Fu W et al. Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels.
Biophys. J., 2002 Nov , 83 (2370-85).

406

Akhtar S et al. Characteristics of brain Kv1 channels tailored to mimic native counterparts by tandem linkage of alpha subunits: implications for K+ channelopathies.
J. Biol. Chem., 2002 May 10 , 277 (16376-82).

407

Felix R et al. Identification of distinct K+ channels in mouse spermatogenic cells and sperm.
Zygote, 2002 May , 10 (183-8).

408

Arroyo EJ et al. Genetic dysmyelination alters the molecular architecture of the nodal region.
J. Neurosci., 2002 Mar 1 , 22 (1726-37).

409

Shimizu Y et al. Cumulative inactivation and the pore domain in the Kv1 channels.
Pflugers Arch., 2002 Mar , 443 (720-30).

410

Maylie B et al. Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel alter hKvbeta 1-induced N-type inactivation.
J. Neurosci., 2002 Jun 15 , 22 (4786-93).

411

Adamson CL et al. Firing features and potassium channel content of murine spiral ganglion neurons vary with cochlear location.
J. Comp. Neurol., 2002 Jun 10 , 447 (331-50).

412

Glazebrook PA et al. Potassium channels Kv1.1, Kv1.2 and Kv1.6 influence excitability of rat visceral sensory neurons.
J. Physiol. (Lond.), 2002 Jun 1 , 541 (467-82).

413

Tian S et al. Regulation of the voltage-gated K+ channel KCNA10 by KCNA4B, a novel beta-subunit.
Am. J. Physiol. Renal Physiol., 2002 Jul , 283 (F142-9).

414

Rea R et al. Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1.
J. Physiol. (Lond.), 2002 Jan 1 , 538 (5-23).

415

Mason DE et al. Molecular basis of voltage-dependent potassium currents in porcine granulosa cells.
Mol. Pharmacol., 2002 Jan , 61 (201-13).

416

Racapé J et al. Characterization of a novel radiolabeled peptide selective for a subpopulation of voltage-gated potassium channels in mammalian brain.
J. Biol. Chem., 2002 Feb 8 , 277 (3886-93).

417

Kerschbaum HH et al. A Shaker homologue encodes an A-type current in Xenopus laevis.
Brain Res., 2002 Feb 8 , 927 (55-68).

418

Gamper N et al. IGF-1 up-regulates K+ channels via PI3-kinase, PDK1 and SGK1.
Pflugers Arch., 2002 Feb , 443 (625-34).

419

Legros C et al. Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
Biochemistry, 2002 Dec 24 , 41 (15369-75).

420

Yao X et al. Expression of KCNA10, a voltage-gated K channel, in glomerular endothelium and at the apical membrane of the renal proximal tubule.
J. Am. Soc. Nephrol., 2002 Dec , 13 (2831-9).

421

Wickenden AD Potassium channels as anti-epileptic drug targets.
Neuropharmacology, 2002 Dec , 43 (1055-60).

422

Kurata HT et al. Amino-terminal determinants of U-type inactivation of voltage-gated K+ channels.
J. Biol. Chem., 2002 Aug 9 , 277 (29045-53).

423

Dodson PD et al. Two heteromeric Kv1 potassium channels differentially regulate action potential firing.
J. Neurosci., 2002 Aug 15 , 22 (6953-61).

424

Mo ZL et al. Dendrotoxin-sensitive K(+) currents contribute to accommodation in murine spiral ganglion neurons.
J. Physiol. (Lond.), 2002 Aug 1 , 542 (763-78).

425

McCormack K et al. Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2).
J. Biol. Chem., 2002 Apr 12 , 277 (13219-28).

426

Rao JN et al. Activation of K(+) channels and increased migration of differentiated intestinal epithelial cells after wounding.
Am. J. Physiol., Cell Physiol., 2002 Apr , 282 (C885-98).

427

Huys I et al. Purification, characterization and biosynthesis of parabutoxin 3, a component of Parabuthus transvaalicus venom.
Eur. J. Biochem., 2002 Apr , 269 (1854-65).

428

Baloh RW et al. Genetics of familial episodic vertigo and ataxia.
Ann. N. Y. Acad. Sci., 2002 Apr , 956 (338-45).

429

Lerche H et al. Ion channels and epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (146-59).

430

Brunner M et al. Characterization of mice with a combined suppression of I(to) and I(K,slow).
Am. J. Physiol. Heart Circ. Physiol., 2001 Sep , 281 (H1201-9).

431

Zhu J et al. Determinants involved in Kv1 potassium channel folding in the endoplasmic reticulum, glycosylation in the Golgi, and cell surface expression.
J. Biol. Chem., 2001 Oct 19 , 276 (39419-27).

432

Friederich P et al. Interaction of volatile anesthetics with human Kv channels in relation to clinical concentrations.
Anesthesiology, 2001 Oct , 95 (954-8).

433

Pirisino R et al. Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.
Br. J. Pharmacol., 2001 Oct , 134 (880-6).

434

Rasband MN et al. Distinct potassium channels on pain-sensing neurons.
Proc. Natl. Acad. Sci. U.S.A., 2001 Nov 6 , 98 (13373-8).

435

Thorneloe KS et al. Molecular composition of 4-aminopyridine-sensitive voltage-gated K(+) channels of vascular smooth muscle.
Circ. Res., 2001 Nov 23 , 89 (1030-7).

436

McDaniel SS et al. Anorexic effect of K+ channel blockade in mesenteric arterial smooth muscle and intestinal epithelial cells.
J. Appl. Physiol., 2001 Nov , 91 (2322-33).

437

London B et al. Targeted replacement of KV1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of I(K,slow) and resistance to drug-induced qt prolongation.
Circ. Res., 2001 May 11 , 88 (940-6).

438

Cox RH et al. Differential expression of voltage-gated K(+) channel genes in arteries from spontaneously hypertensive and Wistar-Kyoto rats.
Hypertension, 2001 May , 37 (1315-22).

439

Liguori R et al. Familial continuous motor unit activity and epilepsy.
Muscle Nerve, 2001 May , 24 (630-3).

440

Boyle ME et al. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve.
Neuron, 2001 May , 30 (385-97).

441

Chung YH et al. Immunohistochemical study on the distribution of six members of the Kv1 channel subunits in the rat cerebellum.
Brain Res., 2001 Mar 23 , 895 (173-7).

442

Tytgat J et al. New polypeptide components purified from mamba venom.
FEBS Lett., 2001 Mar 2 , 491 (217-21).

443

Fili O et al. Direct interaction of a brain voltage-gated K+ channel with syntaxin 1A: functional impact on channel gating.
J. Neurosci., 2001 Mar 15 , 21 (1964-74).

444

Hinck D et al. Gallamine triethiodide selectively blocks voltage-gated potassium channels in Ranvier nodes.
Gen. Physiol. Biophys., 2001 Mar , 20 (83-95).

445

Fry M et al. Cloning and expression of three K+ channel cDNAs from Xenopus muscle.
Brain Res. Mol. Brain Res., 2001 Jun 20 , 90 (135-48).

446

Holmqvist MH et al. Kinetic modulation of Kv4-mediated A-current by arachidonic acid is dependent on potassium channel interacting proteins.
J. Neurosci., 2001 Jun 15 , 21 (4154-61).

447

Hatton WJ et al. Functional and molecular expression of a voltage-dependent K(+) channel (Kv1.1) in interstitial cells of Cajal.
J. Physiol. (Lond.), 2001 Jun 1 , 533 (315-27).

448

Cukovic D et al. A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of alpha-actinin-2.
FEBS Lett., 2001 Jun 1 , 498 (87-92).

449

Brown AA et al. Molecular organization of the nodal region is not altered in spontaneously diabetic BB-Wistar rats.
J. Neurosci. Res., 2001 Jul 15 , 65 (139-49).

450

Ekhterae D et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2001 Jul , 281 (C157-65).

451

Brock MW et al. Selective open-channel block of Shaker (Kv1) potassium channels by s-nitrosodithiothreitol (SNDTT).
J. Gen. Physiol., 2001 Jul , 118 (113-34).

452

Arroyo EJ et al. Internodal specializations of myelinated axons in the central nervous system.
Cell Tissue Res., 2001 Jul , 305 (53-66).

453

Park KH et al. Immunohistochemical study on the distribution of the voltage-gated potassium channels in the gerbil hippocampus.
Neurosci. Lett., 2001 Jan 26 , 298 (29-32).

454

Beeton C et al. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
J. Immunol., 2001 Jan 15 , 166 (936-44).

455

Rasband MN et al. Subunit composition and novel localization of K+ channels in spinal cord.
J. Comp. Neurol., 2001 Jan 1 , 429 (166-76).

456

Friederich P et al. [Epileptic seizures from etomidate? The human Kv1.1 potassium channel in humans]
, 2001 Feb , 36 (100-4).

457

Manganas LN et al. Episodic ataxia type-1 mutations in the Kv1.1 potassium channel display distinct folding and intracellular trafficking properties.
J. Biol. Chem., 2001 Dec 28 , 276 (49427-34).

458

Lambe EK et al. The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex.
J. Neurosci., 2001 Dec 15 , 21 (9955-63).

459

Mathis C et al. Essential role of oligodendrocytes in the formation and maintenance of central nervous system nodal regions.
Development, 2001 Dec , 128 (4881-90).

460

Fathi H B et al. The facilitatory actions of snake venom phospholipase A(2) neurotoxins at the neuromuscular junction are not mediated through voltage-gated K(+) channels.
Toxicon, 2001 Dec , 39 (1871-82).

461

Monaghan MM et al. Experimental localization of Kv1 family voltage-gated K+ channel alpha and beta subunits in rat hippocampal formation.
J. Neurosci., 2001 Aug 15 , 21 (5973-83).

462

Kourrich S et al. Kaliotoxin, a Kv1.1 and Kv1.3 channel blocker, improves associative learning in rats.
Behav. Brain Res., 2001 Apr 8 , 120 (35-46).

463

Chung YH et al. Age-related changes in the distribution of Kv1.1 and Kv1.2 channel subunits in the rat cerebellum.
Brain Res., 2001 Apr 6 , 897 (193-8).

464

Andrews EM et al. Voltage-gated K+ channels in chemoreceptor sensory neurons of rat petrosal ganglion.
Brain Res., 2001 Apr 6 , 897 (199-203).

465

Platoshyn O et al. Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.
Am. J. Physiol. Lung Cell Mol. Physiol., 2001 Apr , 280 (L801-12).

466

Su J et al. The expression and regulation of depolarization-activated K+ channels in the insulin-secreting cell line INS-1.
Pflugers Arch., 2001 Apr , 442 (49-56).

467

Fernandez M et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder.
Ann. Neurol., 2001 Apr , 49 (486-92).

468

Cunningham MO et al. Dendrotoxin sensitive potassium channels modulate GABA but not glutamate release in the rat entorhinal cortex in vitro.
Neuroscience, 2001 , 107 (395-404).

469

Iwasa H et al. Genetic variations in five genes involved in the excitement of cardiomyocytes.
J. Hum. Genet., 2001 , 46 (549-52).

470

van Brederode JF et al. Evidence of altered inhibition in layer V pyramidal neurons from neocortex of Kcna1-null mice.
Neuroscience, 2001 , 103 (921-9).

471

Bhatia KP Familial (idiopathic) paroxysmal dyskinesias: an update.
, 2001 , 21 (69-74).

472

Manganas LN et al. Subunit composition determines Kv1 potassium channel surface expression.
J. Biol. Chem., 2000 Sep 22 , 275 (29685-93).

473

Varshney A et al. Cytoplasmic residues influence the voltage-dependence of the gating of human K+ channels.
Neuroreport, 2000 Sep 11 , 11 (2913-7).

474

Vianna-Jorge R et al. Correolide, a nor-triterpenoid blocker of Shaker-type Kv1 channels elicits twitches in guinea-pig ileum by stimulating the enteric nervous system and enhancing neurotransmitter release.
Br. J. Pharmacol., 2000 Oct , 131 (772-8).

475

Eunson LH et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.
Ann. Neurol., 2000 Oct , 48 (647-56).

476

Knight MA et al. Identification of a novel missense mutation L329I in the episodic ataxia type 1 gene KCNA1--a challenging problem.
Hum. Mutat., 2000 Oct , 16 (374).

477

Ouadid-Ahidouch H et al. KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation.
Biochem. Biophys. Res. Commun., 2000 Nov 19 , 278 (272-7).

478

Kuryshev YA et al. KChAP as a chaperone for specific K(+) channels.
Am. J. Physiol., Cell Physiol., 2000 May , 278 (C931-41).

479

Osipenko ON et al. Potential role for kv3.1b channels as oxygen sensors.
Circ. Res., 2000 Mar 17 , 86 (534-40).

480

Grosse G et al. Expression of Kv1 potassium channels in mouse hippocampal primary cultures: development and activity-dependent regulation.
J. Neurosci., 2000 Mar 1 , 20 (1869-82).

481

Lecomte C et al. Maurotoxin and the Kv1.1 channel: voltage-dependent binding upon enantiomerization of the scorpion toxin disulfide bridge Cys31-Cys34.
J. Pept. Res., 2000 Mar , 55 (246-54).

482

Lang R et al. KCNA10: a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels.
Am. J. Physiol. Renal Physiol., 2000 Jun , 278 (F1013-21).

483

Klockgether T et al. The molecular biology of the autosomal-dominant cerebellar ataxias.
Mov. Disord., 2000 Jul , 15 (604-12).

484

Rolf S et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes.
Naunyn Schmiedebergs Arch. Pharmacol., 2000 Jul , 362 (22-31).

485

Madeja M et al. Sensitivity of native and cloned hippocampal delayed-rectifier potassium channels to verapamil.
Neuropharmacology, 2000 Jan 4 , 39 (202-10).

486

Wang JY et al. Role of K(+) channel expression in polyamine-dependent intestinal epithelial cell migration.
Am. J. Physiol., Cell Physiol., 2000 Feb , 278 (C303-14).

487

Grigg JJ et al. Differential expression of voltage-gated potassium channel genes in auditory nuclei of the mouse brainstem.
Hear. Res., 2000 Feb , 140 (77-90).

488

Nashmi R et al. Abnormal axonal physiology is associated with altered expression and distribution of Kv1.1 and Kv1.2 K+ channels after chronic spinal cord injury.
Eur. J. Neurosci., 2000 Feb , 12 (491-506).

489

Wrisch A et al. Structural differences of bacterial and mammalian K+ channels.
J. Biol. Chem., 2000 Dec 15 , 275 (39345-53).

490

Imbrici P et al. Role of receptor protein tyrosine phosphatase alpha (RPTPalpha) and tyrosine phosphorylation in the serotonergic inhibition of voltage-dependent potassium channels.
Pflugers Arch., 2000 Dec , 441 (257-62).

491

Fajloun Z et al. Chemical synthesis and characterization of Pi1, a scorpion toxin from Pandinus imperator active on K+ channels.
Eur. J. Biochem., 2000 Aug , 267 (5149-55).

492

Nguyen TD et al. Isolation and heterologous expression of two genomic clones encoding Shaker-related potassium channels of trout CNS.
J. Neurosci. Res., 2000 Apr 15 , 60 (174-83).

493

Xu C et al. Molecular basis of voltage-dependent delayed rectifier K+ channels in smooth muscle cells from rat tail artery.
Life Sci., 2000 Apr 14 , 66 (2023-33).

494

Archer SL et al. Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation.
Adv. Exp. Med. Biol., 2000 , 475 (219-40).

495

Arroyo EJ et al. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr.
J. Neurocytol., 1999 Apr-May , 28 (333-47).

496

Rasband MN et al. K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve.
J. Neurocytol., 1999 Apr-May , 28 (319-31).

497

Chiu SY et al. Analysis of potassium channel functions in mammalian axons by gene knockouts.
J. Neurocytol., 1999 Apr-May , 28 (349-64).

498

Schmidt K et al. Heterogeneous expression of voltage-gated potassium channels of the shaker family (Kv1) in oligodendrocyte progenitors.
Brain Res., 1999 Oct 2 , 843 (145-60).

499

Pennington MW et al. Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.
Biochemistry, 1999 Nov 2 , 38 (14549-58).

500

Rho JM et al. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
Dev. Neurosci., 1999 Nov , 21 (320-7).

501

Islas LD et al. Voltage sensitivity and gating charge in Shaker and Shab family potassium channels.
J. Gen. Physiol., 1999 Nov , 114 (723-42).

502

Zuberi SM et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.
Brain, 1999 May , 122 ( Pt 5) (817-25).

503

Bretschneider F et al. External tetraethylammonium as a molecular caliper for sensing the shape of the outer vestibule of potassium channels.
Biophys. J., 1999 May , 76 (2351-60).

504

Jing J et al. Fast inactivation of a brain K+ channel composed of Kv1.1 and Kvbeta1.1 subunits modulated by G protein beta gamma subunits.
EMBO J., 1999 Mar 1 , 18 (1245-56).

505

Galeotti N et al. Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors.
Br. J. Pharmacol., 1999 Mar , 126 (1214-20).

506

Sheikh KA et al. The distribution of ganglioside-like moieties in peripheral nerves.
Brain, 1999 Mar , 122 ( Pt 3) (449-60).

507

Suarez-Kurtz G et al. Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.
J. Pharmacol. Exp. Ther., 1999 Jun , 289 (1517-22).

508

Zhou L et al. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves.
J. Neurosci., 1999 Jul 15 , 19 (5768-81).

509

Wang FC et al. alpha subunit compositions of Kv1.1-containing K+ channel subtypes fractionated from rat brain using dendrotoxins.
Eur. J. Biochem., 1999 Jul , 263 (230-7).

510

Wang FC et al. Identification of residues in dendrotoxin K responsible for its discrimination between neuronal K+ channels containing Kv1.1 and 1.2 alpha subunits.
Eur. J. Biochem., 1999 Jul , 263 (222-9).

511

Bretschneider F et al. Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1).
Eur. J. Neurosci., 1999 Jul , 11 (2403-12).

512

Boland LM et al. Protein kinase C inhibits Kv1.1 potassium channel function.
Am. J. Physiol., 1999 Jul , 277 (C100-10).

513

Chanda B et al. Transplanting the N-terminus from Kv1.4 to Kv1.1 generates an inwardly rectifying K+ channel.
Neuroreport, 1999 Feb 5 , 10 (237-41).

514

Shamotienko O et al. Recreation of neuronal Kv1 channel oligomers by expression in mammalian cells using Semliki Forest virus.
Biochemistry, 1999 Dec 21 , 38 (16766-76).

515

Akhtar S et al. A functional spliced-variant of beta 2 subunit of Kv1 channels in C6 glioma cells and reactive astrocytes from rat lesioned cerebellum.
Biochemistry, 1999 Dec 21 , 38 (16984-92).

516

Patten CD et al. Structural and functional modularity of voltage-gated potassium channels.
FEBS Lett., 1999 Dec 17 , 463 (375-81).

517

Alessandri-Haber N et al. Mapping the functional anatomy of BgK on Kv1.1, Kv1.2, and Kv1.3. Clues to design analogs with enhanced selectivity.
J. Biol. Chem., 1999 Dec 10 , 274 (35653-61).

518

Seifert G et al. Developmental changes in the expression of Shaker- and Shab-related K(+) channels in neurons of the rat trigeminal ganglion.
Brain Res. Mol. Brain Res., 1999 Dec 10 , 74 (55-68).

519

Wissmann R et al. NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel beta-subunit Kvbeta1.1.
J. Biol. Chem., 1999 Dec 10 , 274 (35521-5).

520

Neuberg DH et al. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32.
J. Neurosci. Res., 1999 Dec 1 , 58 (612-23).

521

Mourre C et al. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
J. Pharmacol. Exp. Ther., 1999 Dec , 291 (943-52).

522

Poliak S et al. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.
Neuron, 1999 Dec , 24 (1037-47).

523

Galeotti N et al. The role of potassium channels in antihistamine analgesia.
Neuropharmacology, 1999 Dec , 38 (1893-901).

524

Singer-Lahat D et al. Modal behavior of the Kv1.1 channel conferred by the Kvbeta1.1 subunit and its regulation by dephosphorylation of Kv1.1.
Pflugers Arch., 1999 Dec , 439 (18-26).

525

Arimura K [Antibodies directed to voltage-gated potassium channels in sera from acquired neuromyotonia and related disorders]
Rinsho Shinkeigaku, 1999 Dec , 39 (1235-6).

526

Yeung SY et al. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine.
Br. J. Pharmacol., 1999 Dec , 128 (1609-15).

527

Lee YT et al. Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
Eur. J. Pharmacol., 1999 Aug 13 , 378 (349-56).

528

Terstappen GC Functional analysis of native and recombinant ion channels using a high-capacity nonradioactive rubidium efflux assay.
Anal. Biochem., 1999 Aug 1 , 272 (149-55).

529

Coleman SK et al. Subunit composition of Kv1 channels in human CNS.
J. Neurochem., 1999 Aug , 73 (849-58).

530

D'Adamo MC et al. Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function.
FASEB J., 1999 Aug , 13 (1335-45).

531

Chanda B et al. Exploring the architecture of potassium channels using chimaeras to reveal signal transduction.
Biosci. Rep., 1999 Aug , 19 (301-6).

532

Spauschus A et al. Functional characterization of a novel mutation in KCNA1 in episodic ataxia type 1 associated with epilepsy.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (442-6).

533

Wang Q Regulation of a human neuronal voltage-gated potassium channel (hKv1.1) by protein tyrosine phosphorylation and dephosphorylation.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (447-9).

534

Lombardi SJ et al. Probing the potassium channel Kv beta 1/Kv1.1 interaction using a random peptide display library.
Ann. N. Y. Acad. Sci., 1999 Apr 30 , 868 (427-30).

535

Mathur R et al. Ile-177 and Ser-180 in the S1 segment are critically important in Kv1.1 channel function.
J. Biol. Chem., 1999 Apr 23 , 274 (11487-93).

536

Zhang CL et al. Specific alteration of spontaneous GABAergic inhibition in cerebellar purkinje cells in mice lacking the potassium channel Kv1. 1.
J. Neurosci., 1999 Apr 15 , 19 (2852-64).

537

Shi G et al. Differential asparagine-linked glycosylation of voltage-gated K+ channels in mammalian brain and in transfected cells.
J. Membr. Biol., 1999 Apr 1 , 168 (265-73).

538

Galeotti N et al. Effect of potassium channel modulators in mouse forced swimming test.
Br. J. Pharmacol., 1999 Apr , 126 (1653-9).

539

Ishikawa K et al. Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy.
Muscle Nerve, 1999 Apr , 22 (502-7).

540

Boland LM et al. Episodic ataxia/myokymia mutations functionally expressed in the Shaker potassium channel.
Neuroscience, 1999 , 91 (1557-64).

541

Waldegger S et al. Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes.
Cell. Physiol. Biochem., 1999 , 9 (81-9).

542

Elinder F et al. The functional surface charge density of a fast K channel in the myelinated axon of Xenopus laevis.
J. Membr. Biol., 1998 Sep 15 , 165 (175-81).

543

Zhou L et al. Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves.
J. Neurosci., 1998 Sep 15 , 18 (7200-15).

544

England JD et al. Abnormal distributions of potassium channels in human neuromas.
Neurosci. Lett., 1998 Oct 9 , 255 (37-40).

545

Imredy JP et al. A snake toxin inhibitor of inward rectifier potassium channel ROMK1.
Biochemistry, 1998 Oct 20 , 37 (14867-74).

546

Zhou J et al. Characterization of a slowly inactivating outward current in adult mouse ventricular myocytes.
Circ. Res., 1998 Oct 19 , 83 (806-14).

547

Newcomb R et al. Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas.
Biochemistry, 1998 Nov 3 , 37 (15353-62).

548

Elliott AA et al. Open channel block and open channel destabilization: contrasting effects of phenol, TEA+ and local anaesthetics on Kv1.1 K+ channels.
Toxicol. Lett., 1998 Nov 23 , 100-101 (277-85).

549

Lombardi SJ et al. Structure-activity relationships of the Kvbeta1 inactivation domain and its putative receptor probed using peptide analogs of voltage-gated potassium channel alpha- and beta-subunits.
J. Biol. Chem., 1998 Nov 13 , 273 (30092-6).

550

Harvey AL et al. What can toxins tell us for drug discovery?
Toxicon, 1998 Nov , 36 (1635-40).

551

Song WJ et al. Somatodendritic depolarization-activated potassium currents in rat neostriatal cholinergic interneurons are predominantly of the A type and attributable to coexpression of Kv4.2 and Kv4.1 subunits.
J. Neurosci., 1998 May 1 , 18 (3124-37).

552

D'Adamo MC et al. Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel.
EMBO J., 1998 Mar 2 , 17 (1200-7).

553

London B et al. Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel.
Proc. Natl. Acad. Sci. U.S.A., 1998 Mar 17 , 95 (2926-31).

554

Levy M et al. Activation of a metabotropic glutamate receptor and protein kinase C reduce the extent of inactivation of the K+ channel Kv1.1/Kvbeta1.1 via dephosphorylation of Kv1.1.
J. Biol. Chem., 1998 Mar 13 , 273 (6495-502).

555

Allen ML et al. Cyclic AMP regulates potassium channel expression in C6 glioma by destabilizing Kv1.1 mRNA.
Proc. Natl. Acad. Sci. U.S.A., 1998 Jun 23 , 95 (7693-8).

556

Yazulla S et al. Differential distribution of Shaker-like and Shab-like K+-channel subunits in goldfish retina and retinal bipolar cells.
J. Comp. Neurol., 1998 Jun 22 , 396 (131-40).

557

Martínez F et al. Site directed mutants of Noxiustoxin reveal specific interactions with potassium channels.
FEBS Lett., 1998 Jun 16 , 429 (381-4).

558

Archer SL et al. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.
J. Clin. Invest., 1998 Jun 1 , 101 (2319-30).

559

Hopkins WF Toxin and subunit specificity of blocking affinity of three peptide toxins for heteromultimeric, voltage-gated potassium channels expressed in Xenopus oocytes.
J. Pharmacol. Exp. Ther., 1998 Jun , 285 (1051-60).

560

Clark JD et al. Hyperalgesia in mice lacking the Kv1.1 potassium channel gene.
Neurosci. Lett., 1998 Jul 24 , 251 (121-4).

561

Zerr P et al. Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel.
FEBS Lett., 1998 Jul 24 , 431 (461-4).

562

Koschak A et al. Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom.
J. Biol. Chem., 1998 Jan 30 , 273 (2639-44).

563

Shon KJ et al. kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel.
J. Biol. Chem., 1998 Jan 2 , 273 (33-8).

564

Jäger H et al. Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states.
J. Physiol. (Lond.), 1998 Jan 15 , 506 ( Pt 2) (291-301).

565

Rasband MN et al. Potassium channel distribution, clustering, and function in remyelinating rat axons.
J. Neurosci., 1998 Jan 1 , 18 (36-47).

566

Chen H et al. Cyclosporin A selectively reduces the functional expression of Kir2.1 potassium channels in Xenopus oocytes.
FEBS Lett., 1998 Feb 6 , 422 (307-10).

567

Nguyen TD et al. Molecular structure and expression of shaker type potassium channels in glial cells of trout CNS.
J. Neurosci. Res., 1998 Feb 1 , 51 (284-92).

568

Meiri N et al. Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense.
Proc. Natl. Acad. Sci. U.S.A., 1998 Dec 8 , 95 (15037-42).

569

Kálmán K et al. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide.
J. Biol. Chem., 1998 Dec 4 , 273 (32697-707).

570

Leicher T et al. Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium channel.
J. Biol. Chem., 1998 Dec 25 , 273 (35095-101).

571

Sobko A et al. Heteromultimeric delayed-rectifier K+ channels in schwann cells: developmental expression and role in cell proliferation.
J. Neurosci., 1998 Dec 15 , 18 (10398-408).

572

Blaine JT et al. Heteromultimeric potassium channels formed by members of the Kv2 subfamily.
J. Neurosci., 1998 Dec 1 , 18 (9585-93).

573

Wang Q et al. Modulation of cloned human neuronal voltage-gated potassium channels (hKv1.1 and hKv2.1) by neurosteroids.
Pflugers Arch., 1998 Dec , 437 (49-55).

574

Gratacós E et al. Kv1.1 channel antisense attenuates learning and modulation of dentate polysialylated NCAM.
Neuroreport, 1998 Aug 24 , 9 (2727-31).

575

Hallows JL et al. Expression of Kv1.1, a Shaker-like potassium channel, is temporally regulated in embryonic neurons and glia.
J. Neurosci., 1998 Aug 1 , 18 (5682-91).

576

Zerr P et al. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency.
J. Neurosci., 1998 Apr 15 , 18 (2842-8).

577

Yuan XJ et al. Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells.
Am. J. Physiol., 1998 Apr , 274 (L621-35).

578

Scheffer H et al. Three novel KCNA1 mutations in episodic ataxia type I families.
Hum. Genet., 1998 Apr , 102 (464-6).

579

Höllerer-Beitz G et al. Influence of detergents on the function of cloned potassium channels.
Recept. Channels, 1998 , 5 (61-78).

580

Brandt T et al. Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo).
Audiol. Neurootol., 1997 Nov-Dec , 2 (373-83).

581

Suessbrich H et al. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
FEBS Lett., 1997 Sep 8 , 414 (435-8).

582

Trouet D et al. Use of a bicistronic GFP-expression vector to characterise ion channels after transfection in mammalian cells.
Pflugers Arch., 1997 Sep , 434 (632-8).

583

Koch RO et al. Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology.
J. Biol. Chem., 1997 Oct 31 , 272 (27577-81).

584

Folco E et al. A cellular model for long QT syndrome. Trapping of heteromultimeric complexes consisting of truncated Kv1.1 potassium channel polypeptides and native Kv1.4 and Kv1.5 channels in the endoplasmic reticulum.
J. Biol. Chem., 1997 Oct 17 , 272 (26505-10).

585

Rhodes KJ et al. Association and colocalization of the Kvbeta1 and Kvbeta2 beta-subunits with Kv1 alpha-subunits in mammalian brain K+ channel complexes.
J. Neurosci., 1997 Nov 1 , 17 (8246-58).

586

Blanc E et al. Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels.
Proteins, 1997 Nov , 29 (321-33).

587

Gómez-Hernandez JM et al. Molecular basis for different pore properties of potassium channels from the rat brain Kv1 gene family.
Pflugers Arch., 1997 Nov , 434 (661-8).

588

Jing J et al. Inactivation of a voltage-dependent K+ channel by beta subunit. Modulation by a phosphorylation-dependent interaction between the distal C terminus of alpha subunit and cytoskeleton.
J. Biol. Chem., 1997 May 30 , 272 (14021-4).

589

Orias M et al. Genomic localization of the human gene for KCNA10, a cGMP-activated K channel.
Genomics, 1997 May 15 , 42 (33-7).

590

Pei Q et al. Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain.
Neuroscience, 1997 May , 78 (343-50).

591

Galeotti N et al. An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen.
J. Pharmacol. Exp. Ther., 1997 May , 281 (941-9).

592

Elliott AA et al. Channel-specific effects of n-alkyl sulphate anions on three shaker-related potassium channels expressed in Xenopus oocytes.
Pflugers Arch., 1997 May , 434 (132-6).

593

Elliott AA et al. Voltage-dependent inhibition of RCK1 K+ channels by phenol, p-cresol, and benzyl alcohol.
Mol. Pharmacol., 1997 Mar , 51 (475-83).

594

Suessbrich H et al. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
Br. J. Pharmacol., 1997 Mar , 120 (968-74).

595

Ghelardini C et al. Effect of K+ channel modulation on mouse feeding behaviour.
Eur. J. Pharmacol., 1997 Jun 18 , 329 (1-8).

596

Verma-Kurvari S et al. Regional and cellular expression patterns of four K+ channel mRNAs in the adult rat brain.
Brain Res. Mol. Brain Res., 1997 Jun , 46 (54-62).

597

Smart SL et al. Identification of the delayed rectifier potassium channel, Kv1.6, in cultured astrocytes.
Glia, 1997 Jun , 20 (127-34).

598

Furukawa Y et al. Comparison of accumulative inactivation between the Aplysia K+ channel (AKv1.1a) and its amino-terminal deletion mutant.
Zool. Sci., 1997 Jun , 14 (397-408).

599

Galeotti N et al. Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel.
Eur. J. Pharmacol., 1997 Jul 2 , 330 (15-25).

600

Harvey AL Recent studies on dendrotoxins and potassium ion channels.
Gen. Pharmacol., 1997 Jan , 28 (7-12).

601

Tytgat J et al. Effect of lanthanum on voltage-dependent gating of a cloned mammalian neuronal potassium channel.
Brain Res., 1997 Feb 28 , 749 (232-7).

602

Brahmajothi MV et al. Heterogeneity in K+ channel transcript expression detected in isolated ferret cardiac myocytes.
, 1997 Feb , 20 (388-96).

603

Madeja M et al. Diversity of potassium channels contributing to differences in brain area-specific seizure susceptibility: sensitivity of different potassium channels to the epileptogenic agent pentylenetetrazol.
Eur. J. Neurosci., 1997 Feb , 9 (390-5).

604

Tytgat J et al. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1).
Br. J. Pharmacol., 1997 Dec , 122 (1417-24).

605

Street VA et al. Physical mapping of potassium channel gene clusters on mouse chromosomes three and six.
Genomics, 1997 Aug 15 , 44 (110-7).

606

Meiri N et al. Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat.
Proc. Natl. Acad. Sci. U.S.A., 1997 Apr 29 , 94 (4430-4).

607

Kharrat R et al. Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels.
FEBS Lett., 1997 Apr 14 , 406 (284-90).

608

Madeja M et al. Effects of n-hexane and its metabolites on cloned voltage-operated neuronal potassium channels.
Arch. Toxicol., 1997 , 71 (238-42).

609

Garratt JC et al. Blockade of two voltage-dependent potassium channels, mKv1.1 and mKv1.2, by docosahexaenoic acid.
Eur. J. Pharmacol., 1996 Oct 31 , 314 (393-6).

610

Stephens GJ et al. Studies on the blocking action of human Kv3.4 inactivation peptide variants in the mouse cloned Kv1.1 K+ channel.
J. Physiol. (Lond.), 1996 Oct 1 , 496 ( Pt 1) (145-54).

611

Busch AE et al. Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B.
Pflugers Arch., 1996 Oct , 432 (1094-6).

612

Comu S et al. Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1.
Ann. Neurol., 1996 Oct , 40 (684-7).

613

Elinder F et al. Surface Charges of K channels. Effects of strontium on five cloned channels expressed in Xenopus oocytes.
J. Gen. Physiol., 1996 Oct , 108 (325-32).

614

Wang Z et al. Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits.
J. Biol. Chem., 1996 Nov 8 , 271 (28311-7).